FENOLDOPAM - EFFECT ON ALDOSTERONE SECRETION

被引：1

作者：

DUPONT, AG ^{[1
]}

VANDERNIEPEN, P ^{[1
]}

VOLCKAERT, A ^{[1
]}

SMITZ, J ^{[1
]}

VANSTEIRTEGHEM, AC ^{[1
]}

SIX, RO ^{[1
]}

机构：

[1] VRIJE UNIV BRUSSEL,ACAD HOSP,DEPT RADIOIMMUNOASSAY,B-1090 BRUSSELS,BELGIUM

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1986年 / 21卷 / 02期

关键词：

D O I：

10.1111/j.1365-2125.1986.tb05185.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：243 / 244

页数：2

共 6 条

[1]

AGUILERA G, 1984, FRONT NEUROENDOCRIN, V8, P265

[2] DOPAMINERGIC INHIBITION OF METOCLOPRAMIDE-INDUCED ALDOSTERONE SECRETION IN MAN - DISSOCIATION OF RESPONSES TO DOPAMINE AND BROMOCRIPTINE [J].

CAREY, RM ;

THORNER, MO ;

ORTT, EM .

JOURNAL OF CLINICAL INVESTIGATION, 1980, 66 (01) :10-18

[3] METOCLOPRAMIDE - AN UPDATED REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL USE [J].

HARRINGTON, RA ;

HAMILTON, CW ;

BROGDEN, RN ;

LINKEWICH, JA ;

ROMANKIEWICZ, JA ;

HEEL, RC .

DRUGS, 1983, 25 (05) :451-494

[4] THE EFFECT OF ORAL FENOLDOPAM (SKF 82526-J), A PERIPHERAL DOPAMINE RECEPTOR AGONIST, ON BLOOD-PRESSURE AND RENAL-FUNCTION IN NORMAL MAN [J].

HARVEY, JN ;

WORTH, DP ;

BROWN, J ;

LEE, MR .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 19 (01) :21-27

[5] TONIC DOPAMINERGIC SUPPRESSION OF PLASMA-ALDOSTERONE [J].

NOTH, RH ;

MCCALLUM, RW ;

CONTINO, C ;

HAVELICK, J .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 51 (01) :64-69

[6] DOPAMINERGIC MODULATION OF ALDOSTERONE SECRETION IN MAN IS UNAFFECTED BY GLUCOCORTICOIDS AND ANGIOTENSIN BLOCKADE [J].

SOWERS, JR ;

BRICKMAN, AS ;

SOWERS, DK ;

BERG, G .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1981, 52 (06) :1078-1084

← 1 →